. Oxytocin modulates the onset of murine parturition by competing ovarian and uterine effects. Am J Physiol Regulatory Integrative Comp Physiol 279: R1061-R1067, 2000.-Recent analysis of mice deficient in both oxytocin (OT) and cyclooxygenase-1 has shown that OT exerts significant effects on both the ovarian corpus luteum and the uterine myometrium during pregnancy. To better define the roles of OT during pregnancy, we evaluated OT action and OT receptor regulation in wild-type and OTdeficient knockout (KO) mice. Continuous infusion of OT revealed that OT can either delay labor at low doses or initiate preterm labor at high doses. The infusion rates of OT necessary for these effects were reduced in OT KO mice. The dose of OT that delayed labor also delayed the normal decrease in plasma progesterone late in gestation, implicating a primary effect on the corpus luteum. Consistent with this hypothesis, luteal OT receptor expression exceeded that of the myometrium until luteolysis occurred. We propose that the downregulation of OT receptors in the corpus luteum and induction of OT receptors in the myometrium serve to shift the predominant consequence of OT action during murine pregnancy from labor inhibition to labor promotion. corpus luteum; knockout mice; labor; luteolysis; oxytocin receptor OXYTOCIN (OT), a cyclic nonapeptide produced primarily in the hypothalamic supraoptic and paraventricular nuclei, stimulates contraction of mammary myoepithelial and uterine smooth muscle cells by virtue of its interaction with a specific high-affinity G protein-coupled receptor (2, 6, 7, 13) . OT is one of the most potent uterotonic agents identified, and during late gestation, OT receptors (OTR) are significantly induced in the myometrium in all mammalian species (3, 6, 17). Despite these associations, the physiological importance of OT in modulating the initiation and progression of labor remains unclear. Whereas OT infusion augments uterine contractions and hastens the progression of labor in both human and animal studies (1, 3, 7), mice rendered OT deficient by gene targeting demonstrate no defect in parturition (9, 11, 16) . On the other hand, mice with defects in either prostaglandin synthesis or action, which manifest as delayed or absent labor, initiate labor when a fall in progesterone and induction of uterine OTR occur (9, 14) . We have recently shown that mice with cyclooxygenase (COX)-1 deficiency have markedly impaired generation of PGF 2␣ during pregnancy that results in delayed luteolysis and labor, whereas mice with combined COX-1 and OT deficiency initiate luteolysis and labor at the normal time (9). These mice with combined COX-1 and OT deficiency, however, exhibit prolongation in the duration of labor. On the basis of these findings, we hypothesize that OT exerts a direct effect on the corpus luteum to maintain progesterone production in late murine gestation and, together with prostaglandins, facilitates uterine contractions and the progression of labor at term. Because the rise in prostaglandin production resulting in luteolysis is the primary determinant of labor initiation, the effects of OT deficiency are only evident in the setting of compromised prostaglandin production.
OXYTOCIN (OT), a cyclic nonapeptide produced primarily in the hypothalamic supraoptic and paraventricular nuclei, stimulates contraction of mammary myoepithelial and uterine smooth muscle cells by virtue of its interaction with a specific high-affinity G protein-coupled receptor (2, 6, 7, 13) . OT is one of the most potent uterotonic agents identified, and during late gestation, OT receptors (OTR) are significantly induced in the myometrium in all mammalian species (3, 6, 17) . Despite these associations, the physiological importance of OT in modulating the initiation and progression of labor remains unclear. Whereas OT infusion augments uterine contractions and hastens the progression of labor in both human and animal studies (1, 3, 7) , mice rendered OT deficient by gene targeting demonstrate no defect in parturition (9, 11, 16) . On the other hand, mice with defects in either prostaglandin synthesis or action, which manifest as delayed or absent labor, initiate labor when a fall in progesterone and induction of uterine OTR occur (9, 14) . We have recently shown that mice with cyclooxygenase (COX)-1 deficiency have markedly impaired generation of PGF 2␣ during pregnancy that results in delayed luteolysis and labor, whereas mice with combined COX-1 and OT deficiency initiate luteolysis and labor at the normal time (9) . These mice with combined COX-1 and OT deficiency, however, exhibit prolongation in the duration of labor. On the basis of these findings, we hypothesize that OT exerts a direct effect on the corpus luteum to maintain progesterone production in late murine gestation and, together with prostaglandins, facilitates uterine contractions and the progression of labor at term. Because the rise in prostaglandin production resulting in luteolysis is the primary determinant of labor initiation, the effects of OT deficiency are only evident in the setting of compromised prostaglandin production.
In this current study, we test the hypothesis that OT exerts direct trophic effects on the corpus luteum during murine pregnancy. We demonstrate that differential regulation of OTR in the corpus luteum and myometrium results in the ability of OT to either inhibit or promote the progression of labor depending on the relative expression of OTR in these tissues.
METHODS
Animal husbandry. Wild-type (WT) and OT knockout (KO) mice (C. E. Luedke and L. J. Muglia, unpublished data) were maintained on an outbred (129/Sv ϫ Black Swiss) genetic background. Mice were housed on a 12:12 light-dark cycle with ad libitum access to rodent chow. All mouse protocols were in accordance with National Institutes of Health guidelines and approved by the Animal Care and Use Committee of Washington University School of Medicine, St. Louis, MO. Natural mating of estrous females with stud males was confirmed by detection of a copulation plug the morning following introduction of the female into the male cage. Females were subsequently isolated until the time of analysis to ensure accurate gestation timing, with the morning of copulation plug detection designated 0.5 days gestation.
Continuous infusion of OT. On day 15.5 of gestation, gravid OT KO or WT female mice (mated with OT KO or WT males, respectively) underwent implantation of osmotic minipumps (Alza, Palo Alto, CA) under isoflurane anesthesia. Pumps were loaded with either sterile PBS or OT (Sigma, St. Louis, MO) dissolved in PBS at concentrations necessary to provide 0, 0.12, 1, 2.5, or 5 U/day. Pumps were primed by overnight incubation at 37°C in a sterile tube containing PBS, then implanted subcutaneously. In some OT KO pregnancies (n ϭ 3), gravid females received 150 g indomethacin (5 mg/kg) via gavage 30 min before pump implantation. Time until the onset of labor, defined as delivery of the first pup, was subsequently measured in all pregnancies (n ϭ 3-7 per genotype and dose) by observation of gravid females in the mornings and evenings (9) following pump implantation. Statistical analysis was by ANOVA with significance taken for P Ͻ 0.05. In unmanipulated and vehicle-or OT pumpimplanted pregnancies (n ϭ 3-7), OT KO and WT females underwent retroorbital phlebotomy at 16.0 or 19.0 days postcoitus for measurement of serum progesterone concentration by radioimmunoassay (Diagnostic Products, Los Angeles, CA). In the indomethacin-treated OT KO females, phlebotomy was performed at the time of delivery of the first pup on day 16 for progesterone measurement, and uteri were harvested for PGF 2␣ measurement as we have previously described (9) . Statistical analysis was by ANOVA, with significance taken for P Ͻ 0.05.
In situ hybridization. Ovaries and uteri were fixed by immersion in diethylpyrocarbonate-treated 4% paraformaldehyde in PBS for 24 h at 4°C. Samples were then cryopreserved in 10% sucrose in PBS and embedded in OCT compound (Miles, Elkhart, IN) for sectioning on a cryostat. Tenmicrometer sections were thaw mounted onto Superfrost Plus slides (Fisher Scientific, Pittsburgh, PA) and hybridized to an ␣-[
33 P]UTP-labeled 800-base OTR or a 1.2-kb rat 20␣-hydroxysteroid dehydrogenase antisense riboprobe (10) as previously described (9) . After washing, slides were exposed to Kodak NTB-2 emulsion (Eastman Kodak, Rochester, NY) for 3-10 days, developed, and then counterstained with hematoxylin and eosin.
RNase protection. Five or ten micrograms of total RNA from ovary or uterus, respectively, were subjected to RNase protection assay (RPA) by RPA II Kit (Ambion, Austin, TX) according to the manufacturer's specifications. The OTR antisense RNA probe was generated by digestion of a 1.0-kb mouse OTR cDNA fragment from exon 2 in pBluescript SK IIϩ with ApaL I and labeled with ␣-[ 32 P]CTP (800 Ci/mmol) by transcription with T7 polymerase (Promega, Madison, WI). The product expected from protection of OTR mRNA was 0.38 kb. Each OTR mRNA hybridization signal was corrected for loading and recovery by normalization to mouse cyclophilin A intensity (Ambion, Austin, TX) in the same hybridization reaction. After hybridization and nuclease digestion, samples were subjected to electrophoresis through 6% acrylamide/8 M urea denaturing gels. After electrophoresis, the denaturing gels were transferred to Whatmann 3MM paper and quantitated on a Molecular Dynamics Phosphorimager (Sunnyvale, CA).
Northern blot hybridization. RNA was prepared by the guanidinium thiocyanate-cesium chloride method (4). Ten micrograms of total RNA from uterus and ovary were subjected to electrophoresis through 1.2% agarose-formaldehyde gels and transferred to nitrocellulose membranes. RNA probes specific for mouse OTR or cyclophilin A (as a loading control) mRNAs labeled with ␣-[
32 P]UTP were generated and hybridized as previously described (9) .
Western blot analysis. Cell membrane protein extracts from uterus and ovary of WT mice and thymus from mice harboring an inducible OTR transgene regulated by the tetracycline transactivator (T. Imamura and L. J. Muglia, unpublished data) were prepared by sonication in 5 ml of 10 mM Tris (pH 7.5), 10 mM NaCl, 1 g/ml pepstatin A, 2 g/ml aprotinin, 5 g/ml leupeptin, and 200 M phenylmethanesulfonyl fluoride. The supernatant, after centrifugation at 800 g for 20 min at 4°C, was subjected to centrifugation at 46,000 g for 2 h at 4°C. The subsequent pellet containing membrane proteins was resuspended in 1 ml of 100 mM Na 2 CO 3 (pH 11.5), 1 g/ml pepstatin A, 2 g/ml aprotinin, 5 g/ml leupeptin, and 200 M phenylmethanesulfonyl fluoride for 30 min at 4°C. The resulting suspension was subjected to a second centrifugation at 46,000 g for 2 h at 4°C followed by resuspension of the pellet in 10 mM HEPESpotassium hydroxide (pH 7.5), 1 g/ml pepstatin A, 2 g/ml aprotinin, 5 g/ml leupeptin, and 200 M phenylmethanesulfonyl fluoride. Twelve-microgram aliquots of the extracts were subjected to 10% PAGE and transferred to nitrocellulose. The anti-OTR monoclonal antibody O-2F8 (15) at 1 g/ml (Rohto Pharmaceuticals, Japan) diluted in 0.44 M sodium chloride, 25 mM Tris (pH 8.0), 3 mM potassium chloride, 0.1% Tween-20, and 5% nonfat dry milk was used to detect OTR with visualization using an enhanced chemiluminescent detection kit (Amersham Life Sciences, Arlington Heights, IL) followed by exposure to BioMax film (Eastman Kodak, Rochester, NY). Specific bands of 56 and 69 kDa were found in uterus from WT mice and thymus from transgenic mice with induced OTR expression, corresponding closely in size to products detected in human myometrial cells with this antibody (12) . Equivalent protein loading and transfer was confirmed by Ponceau S staining of the membrane.
RESULTS

Effect of OT infusion in mice.
To determine if modulation of plasma OT concentration alters the timing for initiation of labor, we evaluated the consequences of continuous OT infusion in WT and OT KO mice. In OT KO mice, possible alterations in endogenous OT secretion are removed. Moreover, changes in OT sensitivity as a consequence of chronic OT deficiency can be assessed. WT and OT KO mice at day 15.5 of gestation underwent implantation of osmotic minipumps delivering OT at infusion rates of 0 (vehicle only), 0.12, 1.0, 2.5, or 5 U/day. WT mice receiving OT at rates of 0 or 0.12 U/day showed the onset of labor at the expected time following pump implantation. A significant delay in the onset of labor was observed in WT mice in response to OT infused at 1.0 U/day (onset of labor 4.6 Ϯ 0.38 days after pump placement with 1.0 U/day OT vs. 3.8 Ϯ 0.32 days for vehicle infused, P Ͻ 0.05, Fig. 1 ). When WT mice received OT at the higher infusion rates of 2.5 or 5 U/day, labor occurred prematurely, most often within 24 h of pump implantation. OT KO mice showed a similar pattern of response but at a lower dose range than the WT mice, such that the onset of labor was delayed at the infusion rate of 0.12 U/day and was premature at the rate of 1.0 U/day or above (Fig. 1) . Thus at lower doses, OT infusion delays labor in both genotypes, whereas at higher doses, OT infusion precipitates preterm labor. Interestingly, chronic OT deficiency in the OT KO mice results in increased sensitivity to OT administration.
We investigated the mechanisms by which OT prolonged or precipitated labor by determining the effect of OT infusion on the timing of luteolysis in WT and OT KO mice. As evidence for alteration in the progression of luteolysis, we measured serum progesterone concentration just before the expected time for normal term delivery at a dose that delayed the onset of labor. With pumps implanted at 15.5 days of gestation and delivering OT at an infusion rate of 1.0 U/day, a significant elevation of serum progesterone compared with unmanipulated or vehicle-infused WT mice was found at 19.0 days of gestation (Fig. 2) . Thus OT has the capacity to either directly or indirectly sustain luteal progesterone production late in pregnancy at the 1.0 U/day dose in WT mice. We also analyzed serum progesterone during infusion of 1.0 U/day OT in OT KO mice at day 16.0 and found persistent high levels of progesterone not differing from vehicle-infused OT KO mice despite imminent preterm labor [OT KO vehicle (n ϭ 7) 35.5 Ϯ 3.2 ng/ml vs. 1.0 U/day OT (n ϭ 5) 38.0 Ϯ 4.2 ng/ml].
Although the maintenance of serum progesterone levels preceding delivery in the OT-treated OT KO mice suggested that OT precipitated labor by augmentation of uterine contractions rather than induction of luteolysis, changes in serum progesterone, which ultimately resulted in labor, could have occurred at a time closer to delivery than we analyzed. We sought to further prove that precipitation of preterm labor by the higher doses of OT resulted from direct actions of OT on the myometrium rather than indirect actions causing induction of prostaglandin synthesis with subsequent luteolysis or augmentation of myometrial contractions. Therefore, we blocked prostaglandin synthesis by administering indomethacin before implanting 5 U/day OT pumps and measured serum progesterone and uterine PGF 2␣ concentrations during active labor (n ϭ 3). The dose of indomethacin administered suppressed ovarian PGF 2␣ (Ͻ0.4 pg/mg tissue) and uterine PGF 2␣ (0.7 Ϯ 0.5 mg/pg tissue) concentrations to far below the basal, quiescent levels in each tissue previously described (9) . Despite this profound suppression of PGF 2␣ synthesis, labor occurred as early as 2 h after pump implantation and in association with high serum progesterone concentrations that did not significantly differ from vehicle-treated OT KO females (24.1 Ϯ 2.6 ng/ml).
OTR expression in the ovary and uterus. To determine whether the maintenance of serum progesterone could be a direct effect of OT on the corpus luteum, we performed in situ hybridization analysis of ovary and uterus for detection of OTR mRNA. OTR mRNA was expressed at high levels in the corpus luteum at 16.0 days gestation, with little expression in the uterine myometrium (Fig. 3) . In contrast, just before the onset of labor at 19.0 days gestation, less OTR mRNA was detected in the corpus luteum, whereas significant expression was apparent in the myometrium (Fig. 3) . The decreased expression of OTR in the corpus luteum at 19.0 days gestation cannot be attributed to a general cessation of transcription during luteolysis, because other genes, such as 20␣-hydroxysteroid dehydrogenase (10) , are induced in the corpus luteum at this time (Fig. 3) .
To further confirm the reciprocal regulation of OTR mRNA expression in the ovary and uterus, OTR mRNA concentrations in independent pregnancies of WT and OT KO mice were analyzed using RNase protection. Again, OTR mRNA was detected in the ovary at day 16.0 of gestation and declined in abundance as term approached, in contrast to uterine OTR mRNA, which increased in abundance at term in both WT and OT KO mice (Fig. 4) . Whereas OTR mRNA appeared increased in abundance in OT KO nongravid ovary compared with WT, the difference could have resulted from variation in the stage of the estrous cycle at which the samples were harvested. We found no significant difference in OTR mRNA concentration in either uterus or ovary as a function of genotype during pregnancy, implicating posttranscriptional mechanisms as accounting for the difference in sensitivity between OT KO and WT mice to exogenous OT infusion. There was no apparent difference in sizes of OTR mRNAs comparing uterus and ovary, further suggesting functional OTR was being produced by the corpus luteum (Fig. 5) .
To ensure that OTR mRNA levels were indicative of protein expression, we performed Western blot analysis of uterus and ovary (Fig. 6 ). In agreement with studies performed on human myometrial cells (12), we detected species ranging from 56 to 69 kDa in size. To determine the specificity of detection of OTR in murine tissue, we analyzed transgenic mice with inducible expression of OTR in the thymus (T. Imamura and L. J. Muglia, unpublished data). Clear induction of the 56-kDa species was observed in the transgenic thymus with little change in the 69-kDa form. The 69-kDa form demonstrated little change in the uterus and ovary as well. Abundant expression of OTR protein was found in nongravid uterus and ovary. At 16.5 days of gestation, OTR protein expression was markedly reduced, but still present, in both tissues. In uterus, OTR was induced at days 19.0 and 19.5 (immediately postpartum), whereas in ovary, little change or a decrease in expression was found, consistent with the OTR mRNA findings. Of note, induction of OTR in the uterus before labor was associated with the appearance of species migrating between 56 and 69 kDa, suggesting posttranslational receptor modifications, such as phosphorylation, of the induced 56-kDa form (Fig. 6 ).
DISCUSSION
In this study, we demonstrate that OT can either inhibit or hasten the onset of labor. The findings that OTR localizes to the corpus luteum near the end of mouse pregnancy and that low-dose OT infusion augments progesterone production are in accord with our previous demonstration that mice with combined COX-1 and OT deficiency undergo a fall in plasma progesterone at term without prostaglandin-induced luteolysis (9) . The physiological consequence of the augmentation in luteal function with OT infusion was prolonged gestation both in WT and OT KO mice. At higher doses, even without the 10-to 100-fold increase in OTRs that occurs at term (17) , the uterotonic action of OT predominated such that preterm labor was induced. This uterotonic action of OT before the onset of normal term labor is likely a direct effect on low numbers of OTRs, because concomitant inhibition of prostaglandin biosynthesis did not abrogate this effect, and plasma progesterone remained elevated during labor.
To assess OTR signaling in the absence of endogenous OT, we examined the relative sensitivity of OT KO and WT mice to the OT infusion. Indeed, OT KO mice showed alteration in the timing of parturition at lower doses of OT than WT mice, suggesting increased receptor signaling. The altered dose response to OT in OT KO mice is not due to increased transcription of the OTR gene as demonstrated by our RNase protection assay. Whether the increase in signaling is due to Fig. 5 . Northern blot analysis of uterus and ovary OTR mRNA. Total uterine or ovarian RNA from NG or pregnant females of the gestational age (in days) and genotype given above the corresponding lanes were hybridized to OTR or CYC radiolabeled probes. Sizes of the uterine and ovarian transcripts appear the same. increased OTR protein synthesis, alteration in posttranslational receptor modification, increased receptor numbers on the membrane due to lack of ligand binding, or increased signaling by an unchanged number of receptors is the subject of ongoing studies in our laboratory.
Examination of OTR expression in the ovary and uterus of WT mice near the end of gestation showed abundant expression of OTR mRNA in the corpus luteum at day 16.0 of gestation (before luteolysis) and very little at day 19.0 (during luteolysis). The uterine myometrium showed the opposite pattern, with a low level of OTR mRNA at day 16.0 and a high level on day 19.0. Whereas the OTR protein profile of the uterus closely reflected mRNA changes, the OTR protein level in the ovary at day 16.5 was not as high as might be predicted by the relative amount of OTR mRNA at this time, though the level of expression decreased in a fashion consistent with the mRNA expression. The discordance between OTR mRNA and protein levels in the ovary could reflect regulation of OTR protein expression by translational or posttranslational mechanisms. Additionally, alteration in migration of OTR after induction at term in uterus was detected by Western analysis. The OTR species migrating between 56 and 69 kDa are consistent with alteration in phosphorylation, which could result from receptor modification by a G protein receptor kinase (5) after OT-induced activation as part of the process of augmentation of uterine contractions during labor. Future studies using OT KO and inducible OTR transgenic mice will seek to determine the etiology of these altered OTR species. OT infused at the lower doses was capable of significantly modulating ovarian function, despite the modest receptor protein level, with the result of promoting survival of the corpus luteum and prolonging gestation. At the same time, this low-dose infusion did not effectively activate the low levels of uterine OTRs. The sustained progesterone production would further serve to directly inhibit OTR signaling in the uterus and delay parturition (8) . On the other hand, at higher doses, OT was able to precipitate labor, demonstrating that augmentation of uterine contractions before normal term labor is achievable despite low uterine receptor levels and elevated plasma progesterone concentrations if the level of OT is high enough.
We conclude that whereas the sole absence of OT does not significantly impact the timing of normal term labor in mice, abnormal modulation of OT action can affect the timing for the onset of labor. The lack of measurable alteration in the timing of term labor in OT KO mice may be, in part, explained by the elimination of OT's opposing roles in delaying and promoting labor, which are, in turn, determined by both OT and OTR concentrations. In this light, we propose that one role of the OT/OTR system during normal gestation may be to focus the timing for the onset of labor. Before the induction of uterine OTRs immediately preceding the onset of labor, the primary consequence of OT action would be to augment corpus luteum function and avoid premature labor. During luteolysis, OTR expression is reduced in the corpus luteum and rapidly induced in the uterine myometrium. This allows increased uterine sensitivity to OT without the further augmentation of luteal progesterone production that would occur if OT concentration simply increased globally. Thus labor would begin promptly and progress efficiently without further antagonism from progesterone.
Perspectives
Dysregulated OT expression has significant adverse consequences during pregnancy in the mouse. Surprisingly, one consequence of OT action is to maintain luteal progesterone production and restrain the onset of term labor. We also find that larger increases of OT signaling during gestation, without increases in prostaglandins or significant change in serum progesterone, can result in preterm labor. The ability of OT to cause preterm labor in the mouse despite persistent elevation in serum progesterone, as distinct from luteolysis-dependent paradigms for induction of murine preterm labor, may provide an additional useful model for assessing alterations in myometrial function associated with human preterm labor.
